about
VIGR--a novel inducible adhesion family G-protein coupled receptor in endothelial cellsThe tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells.Effects of a thrombomodulin-derived peptide on monocyte adhesion and intercellular adhesion molecule-1 expression in lipopolysaccharide-induced endothelial cells.An integrated omics analysis: impact of microgravity on host response to lipopolysaccharide in vitro.Pro-inflammatory endothelial cell dysfunction is associated with intersectin-1s down-regulation.Posttranslationally modified proteins as mediators of sustained intestinal inflammation.LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway.Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response.Roles of IL-6-gp130 Signaling in Vascular Inflammation.Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases.LPS-Toll-Like Receptor-Mediated Signaling on Expression of Protein S and C4b-Binding Protein in the Liver.Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions.Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt-NF-κB axis.Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease.Fructose induces prothrombotic phenotype in human endothelial cells : A new role for "added sugar" in cardio-metabolic risk.Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemiaUrocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells.Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection.Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells.Human adipose-derived mesenchymal stem cell-conditioned media suppresses inflammatory bone loss in a lipopolysaccharide-induced murine model.Anti-inflammatory Effects of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) In Vitro and In Vivo.Stretchable impedance sensor for mammalian cell proliferation measurements.Anti-inflammatory effects of Baicalin, Baicalein, and Wogonin in vitro and in vivo.Anti-inflammatory effects of vicenin-2 and scolymoside in vitro and in vivo.Shiga-like toxin inhibition of FLICE-like inhibitory protein expression sensitizes endothelial cells to bacterial lipopolysaccharide-induced apoptosis.Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells.
P2860
Q28269285-E6F8E5FB-F44F-4698-9307-273132BBE87CQ33981015-1B16E36C-B850-431C-B367-E7E2162D3511Q34582931-50C02D63-6A67-4AE5-990D-F6FDF11A8CC9Q34875144-6A92ED97-A13A-4D48-904B-78BAB26BE56EQ34987535-695FADCD-CBE3-4D60-AF1F-47F0ED59CDFCQ35607249-DF69676C-D751-4678-A0F2-5597C6970F2EQ37188649-4DEAFBE0-EBE5-4F8C-8BC4-1AF20C1576A3Q37349166-549825AF-0BFE-4D0B-AB84-583207512257Q37429079-C3BD85A3-61B6-4148-9F19-96493FCDEDE5Q37727431-AD093C14-FC80-48CC-BE80-AB7E15E3B03DQ37786555-B3D4428D-3D1C-45DD-8E3E-E87241678099Q38263347-5C712A13-DD1D-4070-B679-48F9FCB34E9FQ39895185-FF399E8D-D6EB-4AAA-A603-1D9D6F65525FQ40122555-6EF260E1-E0DF-4073-A977-8499C863018BQ40806527-FD5487BE-F800-4031-ACDA-6F4D61FDFA0DQ41817195-72E70313-2288-4833-B191-B542972D4D58Q42589673-9822A4A3-8DAE-4FB3-B2EE-6E156DA0AB99Q42723158-F0AC8A1D-EFFC-4C31-B8D9-E4FA6DB6EEF3Q43947854-F873C7D0-5BCA-4492-B1D6-2E89D9D9716EQ46463936-974655FD-CBD5-46BB-BAC7-617FCC771159Q49816092-BDBF0E2F-5611-4AC1-B747-523BB73C4EACQ50440153-6DD53734-4D86-493F-A2DC-9E7BC9D315ABQ50641248-25B74979-08AB-4D46-BD0B-07A1EF846962Q52653877-14E25AF6-02FB-466A-B4C6-D46E28A8C38AQ52664643-1EC5762D-4F0C-4C77-8F7D-7D8B1C07FD75Q54539609-AF97550B-B813-443B-AE4C-6B926F61C53CQ54592153-90A7FE63-A957-412A-ABE2-60BA8BCA79D5
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
LPS and cytokine-activated endothelium.
@ast
LPS and cytokine-activated endothelium.
@en
LPS and cytokine-activated endothelium.
@nl
type
label
LPS and cytokine-activated endothelium.
@ast
LPS and cytokine-activated endothelium.
@en
LPS and cytokine-activated endothelium.
@nl
prefLabel
LPS and cytokine-activated endothelium.
@ast
LPS and cytokine-activated endothelium.
@en
LPS and cytokine-activated endothelium.
@nl
P2093
P356
P1476
LPS and cytokine-activated endothelium.
@en
P2093
P304
P356
10.1055/S-2000-13214
P577
2000-01-01T00:00:00Z